Investors & Media

Financials

HomeInvestors & MediaFinancials

Status of ABL Bio’s funds

ABL Bio’s surplus funds are held in bank deposit, etc..
In accordance with K-IFRS(Korean International Financial Reporting Standards), they are presented in financial statement as cash and cash equivalents, financial assets at fair value through profit or loss, etc..

The status of ABL Bio’s funds in the last three years is as follows.

(Unit: million KRW)

Status of ABL Bio’s funds list
FY2019 FY2020 2021 Q3
Current Assets
Cash and cash equivalents 91,146 40,658 33,176
Financial assets at fair value through profit or loss 42,142 29,733 22,048
Non-Current Assets
Financial assets at fair value through profit or loss - 20,620 13,795
Total amount of Funds Held 133,288 91,011 69,019

Statement of Financial Position

(Unit : million KRW)

FY 2017, FY 2018, 2019.Q3 list
FY 2019 FY 2020 2021 Q3
Current Assets 134,657 71,920 56,119
Non-Current Assets 8,246 27,975 20,379
Total Assets 142,903 99,895 76,498
Current Liabilities 9,327 7,969 4,166
Non-Current Liabilities 1,568 1,261 1,609
Total Liabilities 10,895 9,230 5,775
Capital Stock 22,652 23,123 23,562
Other Capital 352,641 366,601 373,104
Retained Earnings (243,285) (299,059) (325,943)
Total Equity 132,008 90,665 70,723
Total Equity & Liabilities 142,903 99,895 76,498

Income Statement

(Unit : million KRW)

FY 2017, FY 2018, 2019.Q3 list
FY 2019 FY 2020 2021 Q3
Operating Revenue 3,989 8,104 4,735
Operating Expenses 44,417 67,751 39,242
Operating Profit (40,428) (59,647) (34,507)
Financial Income 3,660 9,671 7,478
Financial Expenses 204 4,354 986
Other Income 9 36 1,136
Other Expenses 40 1,312 5
Income before income taxes (37,004) (55,606) (26,884)
Net Profit (37,004) (55,606) (26,884)